Tag: Biotechnology

Luxa Biotechnology
United States

Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

FORT LEE, N.J. – Luxa Biotechnology LLC (Luxa), a clinical -stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular degeneration (AMD), today announced the appointment of Keith Dionne, Ph.D. as Chief Executive Officer. “I am honored to join Luxa at such an exciting time” Post this An early pioneer in the cell therapy field and a … Continue reading Luxa Biotechnology LLC Appoints Keith E. Dionne, Ph.D., as Chief Executive Officer

Impact Newswire
VedaBio
United States

VedaBio Appoints Randy Rasmussen, Former CEO of BioFire Diagnostics, to Board of Directors

Renowned Molecular Diagnostics Leader Joins as VedaBio Enters its Next Phase of Development SAN DIEGO – VedaBio, a pioneering biotechnology company at the forefront of molecular detection, today announced the appointment of Randy Rasmussen, Ph.D., to its Board of Directors. Dr. Rasmussen, a visionary in the molecular diagnostics field with over 30 years of experience, brings deep industry knowledge to VedaBio as the company advances … Continue reading VedaBio Appoints Randy Rasmussen, Former CEO of BioFire Diagnostics, to Board of Directors

Impact Newswire
Prothena
Europe

Prothena Announces Leadership Team Updates

DUBLIN – Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that Chad Swanson, Ph.D., has been appointed Chief Development Officer and will assume leadership of clinical development and medical functions. Chad will join Prothena’s executive leadership team and will report to Gene Kinney, Ph.D., President and Chief Executive Officer. Hideki … Continue reading Prothena Announces Leadership Team Updates

Impact Newswire
Nextleaf
Global

Nextleaf Announces the Appointment of Chief Executive Officer

September 26, 2024 Vancouver, British Columbia–(Newsfile Corp. – September 26, 2024) – Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”), a leading life science firm and licensed cannabis processor, is pleased to announce the permanent appointment of Emma Andrews as the Chief Executive Officer of the Company. Appointment of Chief Executive Officer The Board of Directors of the Company (the … Continue reading Nextleaf Announces the Appointment of Chief Executive Officer

Impact Newswire
Eurofins
Europe

Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment

Pairing customer-centric support and tailored assessments to trace raw material origin in supply chains. NORTHAMPTON, United Kingdom – Eurofins Sustainability Services (Paris:ERF), a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a deforestation impact assessment. The European Union’s Deforestation Regulation (EUDR) aims to prevent the import and sale of products linked to deforestation in the EU … Continue reading Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment

Impact Newswire
ADOCIA
Europe

ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

LYON, France–(BUSINESS WIRE)–Regulatory News: “We have had the time for a thorough transition with Mathieu, and I have come to appreciate his skills and strategic vision. Lastly, I would like to thank Gérard and Olivier for trusting me and for the intense and rewarding years we have spent together.” Post this Adocia (Euronext Paris: FR0011184241 – ADOC, the “Company”), a clinical-stage biopharmaceutical company focused on … Continue reading ADOCIA Announces Appointment of Mathieu‑William Gilbert as Chief Financial Officer

Impact Newswire
Accellix
United States

Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

SAN JOSE, Calif. & JERUSALEM – Accellix, Inc., the leading sample to answer flow cytometry GMP platform company, is pleased to announce the appointment of Greg Hamilton as Chief Executive Officer and member of the Board effective September 23, 2024. He brings over 25 years of management experience in molecular diagnostics, life science tools, manufacturing and professional service industries as the company ramps growth in … Continue reading Accellix Appoints Greg Hamilton as Chief Executive Officer as Company Accelerates Growth in Cell Therapy and Blood Bank Markets

Impact Newswire
Prilenia
United States

Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Expanded leadership team positioned to advance the company’s development and commercialization plans NAARDEN, The Netherlands & WALTHAM, Mass. – Prilenia Therapeutics B.V., a clinical stage biotechnology company focused on the urgent mission to develop novel therapeutics to slow the progression of neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of two key leaders to its management team – Mr. Rob Lauzen as Chief Financial … Continue reading Prilenia Appoints Rob Lauzen as Chief Financial Officer and Jason Marks as Chief Legal Officer

Impact Newswire